Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Ruilope, L.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Other
(3)
+
-
Availability
Metadata Only
(9)
+
-
Creation Date
2010
(5)
+
-
2012
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(9)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(9)
+
-
Topic
albuminuria
(3)
+
-
Author
Ruilope, L.M.
(9)
+
-
Haller, H.
(7)
+
-
Ito, S.
(6)
+
-
Izzo, J.L.
(6)
+
-
Januszewicz, A.
(6)
+
-
Katayama, S.
(6)
+
-
Menne, J.
(6)
+
-
Mimran, A.
(6)
+
-
Rabelink, T.J.
(6)
+
-
Ritz, E.
(6)
+
-
Rump, L.C.
(6)
+
-
Viberti, G.
(6)
+
-
Banegas, J.R.
(2)
+
-
Cerezo, C.
(2)
+
-
Cruz, J.J. de la
(2)
+
-
Garcia-Donaire, J.A.
(2)
+
-
Rabelink, A.J.
(2)
+
-
Segura, J.
(2)
+
-
Show more
Language
en
(9)
+
-
Search results
(1 - 9 of 9)
show grid
show list
save search
Predictors for the development of microalbuminuria and interaction with renal function
Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
Microalbuminuria breakthrough under chronic renin-angiotensin-aldosterone system suppression
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes
Office and ambulatory pulse pressure-association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study)
TRENDS IN ALBUMINURIA UNDER RENIN-ANGIOTENSIN SYSTEM SUPPRESSION
PREVENTION OF MICROALBUMINURIA IN TYPE 2 DIABETES (ROADMAP TRIAL)
PREVENTION OF MICROALBUMINURIA: PREDICTORS FOR A GOOD RESPONSE TO OLMESARTAN TREATMENT (ROADMAP TRIAL)
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study